$17.17 0.12 (+0.70%)
2/10/2012 4:00 PM

Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Recs

0
Player Avatar topsecret09 (60.76) Submitted: 9/20/2009 4:49:34 PM : Underperform Start Price: $13.10 AMLN Score: +22.80

I love the biotechs,but there Is heavy insider selling here... TS

Report this Post Add Comment

Featured Broker Partners


Advertisement